86
Views
3
CrossRef citations to date
0
Altmetric
Original Research

In silico ordinary differential equation/partial differential equation hemodialysis model estimates methadone removal during dialysis

, , , , , & show all
Pages 417-429 | Published online: 22 Jul 2015

References

  • BorgLKravetsIKreekMJThe pharmacology of long-acting as contrasted with short-acting opioidsRiesRKMillerSCFielinDAPrinciples of Addiction MedicineFourth edPhiladelphia, PALippincott Wiliamms and Wilkins2009117132
  • FerrariAPio Rosario CocciaCBertoliniASternieriEMethadone-metabolism, pharmacokinetics, and interactionsPharmacol Res200450655155915501692
  • FosterDJSomogyiAABochnerFMethadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4Br J Clin Pharmacol199947440341210233205
  • GadelSCraffordAReginaKKharaschEDMethadone N-demethylation by the common CYP2B6 allelic variant CYP2B6.6Drug Metab Dispos201341470971323298862
  • GerberJGRhodesRJGalJStereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19Chirality2004161364414628297
  • KreekMJKalismanMIrwinMJafferyNFBiliary secretion of methadone and methadone metabolism in manRes Commun Chem Pathol Pharmacol198029167787403680
  • ShaiovaLDemystifying opioid conversion calculations, a guide for effective dosing by Mary Lynn McPhersonJ Palliat Med2011145668
  • EapCBBuclinTBaumannPInterindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependenceClin Pharmacokinet200241141153119312405865
  • SterniniCPatiernoSSelmerISKirchgessnerAThe opioid system in the gastrointestinal tractNeurogastroenterol Motil200416Suppl 231615357847
  • KreekMJSchecterAJGutjahrCLHechtMMethadone use in patients with chronic renal diseaseDrug Alcohol Depend1980531972056986247
  • SternbyJPNilssonAGaredLJDiffusive-convective mass transfer rates for solutes present on both sides of a dialyzer membraneASAIO J200551324625115968955
  • PerlmanRGiladiHBrechtKIntradialytic clearance of opioids: Methadone versus hydromorphonePain2013154122794280023973378
  • AtkinsonTJFudinJWegrzynELBettingerJJDialysis, opioids, and pain management: Where’s the evidence?Practical Pain Management20141484957
  • KreekMJBorgLDucatERayBPharmacotherapy in the treatment of addiction: methadoneJ Addict Dis201029220021620407977
  • BostonRCMoatePJA novel minimal model to describe NEFA kinetics following an intravenous glucose challengeAm J Physiol Regul Integr Comp Physiol20082944R1140R114718234748
  • BostonRCMoatePJNEFA minimal model parameters estimated from the oral glucose tolerance test and the meal tolerance testAm J Physiol Regul Integr Comp Physiol20082952R395R40318565832
  • SchiesserWEHemodialyzer dynamicsSchiesserWEPartial Differential Equation Analysis in Biomedical EngineeringNew YorkCambridge University Press2013284299
  • SchiesserWEThe Numerical Method of Lines Integration of Partial Differential EquationsSan DiegoAcademic Press1991
  • ClarkWRGaoDProperties of membranes used for hemodialysisSemin Dial200215319119512100457
  • SakaiKDialysis membranes for blood purificationFront Med Biol Eng200010211712910898241
  • TortoriciMACutlerDZhangLPfisterMDesign, conduct, analysis, and interpretation of clinical studies in patients with impaired kidney functionJ Clin Pharmacol2012521 Suppl109S118S22232746
  • LiangHRFoltzRLMengMBennettPMethod development and validation for quantitative determination of methadone enantiomers in human plasma by liquid chromatography/tandem mass spectrometryJ Chromatogr B Analyt Technol Biomed Life Sci20048062191198
  • FudinJPerkinsROpioid pharmacokinetics and expected metabolites Available from: http://paindrcom/wp-content/uploads/2012/05/Opioid-Serum-Predictability-and-Metabolitespdf2011Accessed February 4, 2015
  • SchiesserWEDifferential Equation Analysis in Biomedical Science and Engineering: Ordinary Differential Equation Applications with RHoboken, New JerseyJohn Wiley and Sons, Inc2014
  • SchiesserWEDifferential Equation Analysis in Biomedical Science and Engineering: Partial Differential Equation Applications with RHoboken, New JerseyJohn Wiley and Sons, Inc2014
  • ChowSCShaoJWangHA note on sample size calculation for mean comparisons based on noncentral t-statisticsJ Biopharm Stat200212444145612477068
  • GriffithsGWSchiesserWETraveling Wave Analysis of Partial Differential EquationsBoston, MAAcademic Press2012
  • BhimaniJPOusephRWardRAEffect of increasing dialysate flow rate on diffusive mass transfer of urea, phosphate, and β2-microglobulin during clinical haemodialysisNephrol Dial Transplant201025123990399520543211
  • LeypoldtJKCheungAKEffect of low dialysate flow rate on hemodialyzer mass transfer area coefficients for urea and creatinineHome Hemodial Int199935154
  • MeyerTWLeeperECBartlettDWIncreasing dialysate flow and dialyzer mass transfer area coefficient to increase the clearance of protein-bound solutesJ Am Soc Nephrol20041571927193515213283
  • LuoFJPatelKPMarquezIOPlummerNSHosttetterTHMeyerTWEffect of increasing dialyzer mass transfer area coefficient and dialysate flow on clearance of protein-bound solutes: a pilot crossover trialAm J Kidney Dis20095361042104919394728
  • ŠeferSDegoricijaVAbout drug dialyzabilityActa Clin Croat200342257267
  • NilssonMIÄnggårdEHolmstrandJGunneLMPharmacokinetics of methadone during maintenance treatment: adaptive changes during the induction phaseEur J Clin Pharmacol19822243433497106170
  • MeresaarUNilssonMIHolmstrandJAnggardESingle dose pharmacokinetics and bioavailability of methadone in man studied with a stable isotope methodEur J Clin Pharmacol19812064734787286059
  • LinaresOALinaresALComputational opioid prescribing: A novel application of clinical pharmacokineticsJ Pain Palliat Care Pharmacother201125212513521657860
  • GarridoMJAguirreCTrocónizIFAlpha 1-acid glycoprotein (AAG) and serum protein binding of methadone in heroin addicts with abstinence syndromeInt J Clin Pharmacol Ther2000381354010667835
  • FainsingerRSchoellerTBrueraEMethadone in the management of cancer pain: a reviewPain19935221371478455961
  • United States PharmacopeiaMethadone HCl Safety Data SheetUSP2014 Available from: http://www.usp.org/pdf/EN/referenceStandards/msds/1398009.pdfAccessed January 28, 2015
  • FernerREPost-mortem clinical pharmacologyBr J Clin Pharmacol200866443044318637886
  • MannholdRDrossKPRekkerRFDrug lipophilicity in QSAR practice: I. A comparison of experimental with calculative approachesMolecular Informatics1990912128
  • FurlanVHafiADessallesMCBouchezJCharpentierBTaburetAMMethadone is poorly removed by dialysisNephrol Dial Transplant199914125425510052536
  • GwittPRPerrierDPlasma protein binding and distribution characteristics of drugs as indices of their hemodialyzabilityClin Pharmacol Ther1978242154161679594
  • KellerFWilmsHSchultzeGOffermanGMolzahnMEffect of plasma protein binding, volume of distribution and molecular weight on the fraction of drugs eliminated by hemodialysisClin Nephrol19831942012056851257
  • BellJSeresVBowdronPLewisJBateyRThe use of serum methadone levels in patients receiving methadone maintenanceClin Pharm Ther1988436623629
  • LoimerNSchmidRGrunbergerJJagschRLinzmayerLPresslichOPathophysiological reactions in methadone maintenance patients do not correlate with methadone plasma levelsPsychopharmacology (Berl)199110345385402062987
  • HolmstrandJAnggårdEGunneLMMethadone maintenance: plasma levels and therapeutic outcomeClin Pharmacol Ther1978232175180620477
  • TennantFSJrInadequate plasma concentrations in some high-dose methadone maintenance patientsAm J Psychiatry198714410134913503661772
  • TennantFShannonJCocaine abuse in methadone maintenance patients is associated with low serum methadone concentrationsJ Addict Dis199514167747632748
  • TennantFOpioid serum concentrations in patients with chronic painJ Palliat Med20071061253125518095801
  • JungBFReidenbergMMInterpretation of opioid levels: comparison of blood levels during chronic pain therapy to levels from forensic autopsiesClin Pharmacol Ther200577432433415903130
  • HiltunenAJBeckOHjemdahlPRated well-being in relation to plasma concentrations of l- and d-methadone in satisfied and dissatisfied patients on methadone mainenance treatmentPsychopharmacology (Berl)1999143438539310367556
  • RumpfKWRiegerJAnsogRDohtBSchelerFBinding of antibiotics by dialysis membranes and its clinical relevanceProc Eur Dial Transplant Assoc19781460760923529
  • PubChem [homepage on the Internet](-)-Methadone hydrochloride compound summary for CID 20055402 Available from: http://pubchem.ncbi.nlm.nih.gov/compound/20055402Accessed January 28, 2015
  • GrossmanDFKoppKFFreyJTransport of urea by erythrocytes during hemodialysisProc Eur Dial Transplant Assoc19684250253
  • SargentJAGotchFAPrinciples and biophysics of dialysisMajerJFReplacement of Renal Function by Dialysis3rd edDordrechtKluwer198987143
  • FournierRLBasic Transport Phenomena in Biomedical Engineering3rd edBoca RatonCRC Press2012
  • DoleVPKreekMJMethadone plasma level: sustained by a reservoir of drug in tissueProc Natl Acad Sci U S A1973701104509643